Molecular and imaging biomarker responses to brain mutant HTT lowering in a mouse model of Huntington disease
{{output}}
Therapies targeting mutant huntingtin (mHTT) reduction in the brain hold promise as disease-modifying treatments for Huntington disease (HD), necessitating biomarkers that accurately reflect treatment response. We evaluated candidate molecular and imaging biom... ...
